Abiopharma

🔍 WELCH M SCOTT (Director)

Company: PATRICK INDUSTRIES INC (PATK)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $88.225 per share (Direct)
  Date: 2026-05-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 156,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 50 shares of Common Stock at $88.41 per share (Direct)
  Date: 2026-05-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,192.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: H | shares_owned_after: 31,772.00

Footnotes:

• F1: Reflects shares purchased by the Reporting Person's spouse for which the Reporting Person disclaims beneficial ownership.
• F2: The price quoted in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $85.50 to $88.975, inclusive. The reporting person undertakes to provide to Patrick Industries, Inc., any security holder of Patrick Industries, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the price range set forth in this footnote.
• F3: Reflects purchases of shares of the issuer through an entity that is controlled by the reporting person in which the reporting person has a pecuniary interest. The reporting person disclaims beneficial ownership of other shares purchased by the entity. The amount of securities benefically owned following the reported transaction represent the reporting person's pecuniary interest percentage.